X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (515) 515
index medicus (489) 489
female (297) 297
male (255) 255
lymphoproliferative disorders - chemically induced (214) 214
middle aged (198) 198
aged (164) 164
adult (146) 146
immunosuppressive agents - adverse effects (141) 141
lymphoproliferative disorders (141) 141
methotrexate - adverse effects (106) 106
hematology (100) 100
oncology (100) 100
arthritis, rheumatoid - drug therapy (88) 88
epstein-barr-virus (88) 88
transplantation (85) 85
lymphoma (83) 83
cancer (81) 81
methotrexate (80) 80
lymphoproliferative disorders - drug therapy (76) 76
therapy (76) 76
risk factors (68) 68
lymphoproliferative disorders - pathology (63) 63
animals (61) 61
immunology (61) 61
rheumatoid-arthritis (60) 60
antirheumatic agents - adverse effects (59) 59
rheumatoid arthritis (59) 59
immunosuppression (58) 58
immunosuppressive agents - therapeutic use (57) 57
epstein-barr virus (56) 56
lymphomas (56) 56
risk (54) 54
disease (53) 53
methotrexate - therapeutic use (51) 51
surgery (51) 51
child (50) 50
antineoplastic agents - adverse effects (49) 49
adolescent (48) 48
aged, 80 and over (48) 48
retrospective studies (47) 47
abridged index medicus (46) 46
antibodies, monoclonal - adverse effects (46) 46
lymphoproliferative disorder (46) 46
lymphoproliferative disorders - immunology (46) 46
rituximab (46) 46
treatment outcome (46) 46
pathology (45) 45
lymphoproliferative disorders - etiology (44) 44
lymphoproliferative disorders - virology (43) 43
chemotherapy (42) 42
immunotherapy (40) 40
care and treatment (37) 37
lymphoproliferative disorders - diagnosis (37) 37
dermatology (36) 36
lymphoproliferative disorders - complications (36) 36
medicine & public health (36) 36
chronic lymphocytic-leukemia (35) 35
infection (35) 35
non-hodgkins-lymphoma (35) 35
antibodies, monoclonal - therapeutic use (34) 34
incidence (34) 34
antirheumatic agents - therapeutic use (33) 33
epstein-barr virus infections - complications (33) 33
leukemia (33) 33
health aspects (32) 32
rheumatology (32) 32
cyclosporine - adverse effects (31) 31
time factors (31) 31
antineoplastic agents - therapeutic use (30) 30
herpesvirus 4, human - isolation & purification (30) 30
lymphocytes (30) 30
medicine, general & internal (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
child, preschool (29) 29
patient (29) 29
antibodies, monoclonal, humanized (28) 28
diagnosis, differential (28) 28
rheumatoid factor (28) 28
follow-up studies (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
lymphoma - chemically induced (25) 25
lymphoma, large b-cell, diffuse - chemically induced (25) 25
pharmacology & pharmacy (25) 25
tacrolimus - adverse effects (25) 25
lymphoproliferative disease (24) 24
lymphoproliferative disorders - genetics (24) 24
mice (24) 24
neoplasms - chemically induced (24) 24
tumors (24) 24
b-cell lymphoma (23) 23
gastroenterology & hepatology (23) 23
herpesvirus 4, human (23) 23
immunosuppression - adverse effects (23) 23
alemtuzumab (22) 22
antibodies, monoclonal, murine-derived (22) 22
epstein-barr virus infections - chemically induced (22) 22
fludarabine (22) 22
graft rejection - prevention & control (22) 22
immunosuppressive agents - administration & dosage (22) 22
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (521) 521
French (9) 9
Japanese (8) 8
Spanish (5) 5
German (3) 3
Danish (1) 1
Hungarian (1) 1
Italian (1) 1
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 405 - 417
We describe a series of Epstein Barr virus (EBV)-positive circumscribed, ulcerative lesions associated with various types of immunosuppression (IS). The study... 
Immunosuppression | Lymphoprolifeative | Epstein Barr virus | Mucocutaneous | SURGERY | CELL LYMPHOPROLIFERATIVE DISORDERS | OPTIMAL PRIMER SELECTION | NON-HODGKINS-LYMPHOMAS | immunosuppression | lymphoproliferative | PERIPHERAL-BLOOD | PATHOLOGY | CD8(+) T-CELLS | LYMPHOCYTE SUBPOPULATIONS | mucocutaneous | CYTOMEGALOVIRUS SEROPOSITIVITY | CHAIN-REACTION ANALYSIS | ELDERLY-PATIENTS | EPSTEIN-BARR-VIRUS | Immunohistochemistry | Recurrence | Humans | Middle Aged | Lymphoproliferative Disorders - chemically induced | Male | Skin Ulcer - immunology | Gastrointestinal Diseases - virology | T-Lymphocytes - virology | Epstein-Barr Virus Infections - etiology | Epstein-Barr Virus Infections - therapy | T-Lymphocytes - drug effects | Aged, 80 and over | B-Lymphocytes - virology | Gastrointestinal Diseases - pathology | Skin Diseases, Infectious - virology | Skin Diseases, Infectious - pathology | Mouth Mucosa - immunology | Immune Tolerance | Gastrointestinal Diseases - therapy | Lymphoproliferative Disorders - pathology | Epstein-Barr Virus Infections - pathology | B-Lymphocytes - immunology | Mouth Mucosa - virology | Remission, Spontaneous | T-Lymphocytes - immunology | Oral Ulcer - pathology | Skin Diseases, Infectious - immunology | Age Factors | Oral Ulcer - immunology | Lymphoproliferative Disorders - immunology | Lymphoproliferative Disorders - therapy | Oral Ulcer - chemically induced | Mouth Mucosa - drug effects | In Situ Hybridization | Epstein-Barr Virus Infections - chemically induced | Polymerase Chain Reaction | Adult | Female | Skin Ulcer - virology | Skin Diseases, Infectious - therapy | Gastrointestinal Diseases - immunology | Skin Ulcer - therapy | Epstein-Barr Virus Infections - immunology | Gene Rearrangement, T-Lymphocyte | Lymphoproliferative Disorders - virology | Skin Diseases, Infectious - chemically induced | Treatment Outcome | Skin Ulcer - chemically induced | Genes, Immunoglobulin | B-Lymphocytes - drug effects | Oral Ulcer - therapy | Skin Ulcer - pathology | Immunosuppressive Agents - adverse effects | Aged | Oral Ulcer - virology | Gastrointestinal Diseases - chemically induced | Index Medicus | Muco-cutaneous | Lymphoproliferative
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1617 - 1625
Journal Article
Cancer Science, ISSN 1347-9032, 06/2017, Volume 108, Issue 6, pp. 1271 - 1280
Journal Article
European Journal of Haematology, ISSN 0902-4441, 07/2013, Volume 91, Issue 1, pp. 20 - 28
Journal Article
Journal Article
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2016, Volume 69, Issue 5, pp. 587 - 594
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 02/2014, Volume 41, Issue 2, pp. 293 - 299
Journal Article
Journal Article